Delivery Order SPE2DB22D1202-SPE2DB25FVLP5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,176.58 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA. The product will be delivered to the company's Conshohocken, Pennsylvania location, where...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ultane 250 ML pen bottles with a ceiling value of $1,347.64. This firm fixed price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Ultane 250 ml pen bottles. The contract has a ceiling value of $1,251.38 and is classified as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025. The place of performance is located in Conshohocken, Pennsylvania, which is also the company's corporate headquarters. This award was not set aside for small businesses or...
- The Defense Logistics Agency awarded a $1,202.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ultane 250 ml pen bottles. This firm fixed price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mL of Ultane in a pen bottle configuration, valued at $2,596.98. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through...
- This delivery order, awarded September 18, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Ultane 250 ML pen bottles at a firm fixed price of $2,355.61, with completion scheduled for September 19, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,667.16 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 4565818463 ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product, with an ultimate completion date of September 17, 2024. The contract is not set aside and serves as a delivery order against a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for Ultane Liquid 250ML with a ceiling value of $3,202.32. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on May 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLP5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills delivery orders across DLA's medical supply chain, supporting defense healthcare systems and other government agencies with brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/17/25 |